The total healthcare costs for IS. by Hee Jung Son (14285076)

“…Among surgical treatments, the proportions of corpectomy and anterior fusion declined, while proportion of incision and drainage increased (<i>P</i> < 0.05, respectively). The total healthcare costs increased 2.9-fold from $29,821,391.65 in 2010 to $86,815,775.81 in 2019 with a significant increase in the ratio to gross domestic product. …”

Composite intangible cost. by Richmond Owusu (10219217)

“…There was a significant difference between the total costs across the comorbidities (X²=8.58, p = 0.0137). …”

Image_2_Sub-MIC antibiotics increased the fitness cost of CRISPR-Cas in Acinetobacter baumannii.tif by Ting Yu (156230)

“…However, under sub-MIC conditions, its function and the ability to inhibit the energy required for efflux pumps are reduced, resulting in an increased fitness cost and loss of competitive advantage.…”

Table_3_Sub-MIC antibiotics increased the fitness cost of CRISPR-Cas in Acinetobacter baumannii.xlsx by Ting Yu (156230)

“…However, under sub-MIC conditions, its function and the ability to inhibit the energy required for efflux pumps are reduced, resulting in an increased fitness cost and loss of competitive advantage.…”

Image_4_Sub-MIC antibiotics increased the fitness cost of CRISPR-Cas in Acinetobacter baumannii.tif by Ting Yu (156230)

“…However, under sub-MIC conditions, its function and the ability to inhibit the energy required for efflux pumps are reduced, resulting in an increased fitness cost and loss of competitive advantage.…”

Table_4_Sub-MIC antibiotics increased the fitness cost of CRISPR-Cas in Acinetobacter baumannii.XLSX by Ting Yu (156230)

“…However, under sub-MIC conditions, its function and the ability to inhibit the energy required for efflux pumps are reduced, resulting in an increased fitness cost and loss of competitive advantage.…”

Image_3_Sub-MIC antibiotics increased the fitness cost of CRISPR-Cas in Acinetobacter baumannii.tif by Ting Yu (156230)

“…However, under sub-MIC conditions, its function and the ability to inhibit the energy required for efflux pumps are reduced, resulting in an increased fitness cost and loss of competitive advantage.…”

Image_5_Sub-MIC antibiotics increased the fitness cost of CRISPR-Cas in Acinetobacter baumannii.tif by Ting Yu (156230)

“…However, under sub-MIC conditions, its function and the ability to inhibit the energy required for efflux pumps are reduced, resulting in an increased fitness cost and loss of competitive advantage.…”

Table_1_Sub-MIC antibiotics increased the fitness cost of CRISPR-Cas in Acinetobacter baumannii.docx by Ting Yu (156230)

“…However, under sub-MIC conditions, its function and the ability to inhibit the energy required for efflux pumps are reduced, resulting in an increased fitness cost and loss of competitive advantage.…”

Image_6_Sub-MIC antibiotics increased the fitness cost of CRISPR-Cas in Acinetobacter baumannii.TIF by Ting Yu (156230)

“…However, under sub-MIC conditions, its function and the ability to inhibit the energy required for efflux pumps are reduced, resulting in an increased fitness cost and loss of competitive advantage.…”

Table_2_Sub-MIC antibiotics increased the fitness cost of CRISPR-Cas in Acinetobacter baumannii.docx by Ting Yu (156230)

“…However, under sub-MIC conditions, its function and the ability to inhibit the energy required for efflux pumps are reduced, resulting in an increased fitness cost and loss of competitive advantage.…”

Image_1_Sub-MIC antibiotics increased the fitness cost of CRISPR-Cas in Acinetobacter baumannii.tiff by Ting Yu (156230)

“…However, under sub-MIC conditions, its function and the ability to inhibit the energy required for efflux pumps are reduced, resulting in an increased fitness cost and loss of competitive advantage.…”

Cost profile of breast cancer treatment. by Patience Gyamenah Okyere Asante (16865846)

Subjects:

Total cost (treatment and premature mortality costs) among population with overweight and obesity as percent of GDP in 2020 and 2021. by Adeyemi Okunogbe (9101644)

Subjects:

The trend of patient characteristics, risk factors, and risk scores. by Ayako Shoji (78037)

Subjects:

Factors related to risk scores. by Ayako Shoji (78037)

Subjects:

Fig 4 - by Ayako Shoji (78037)

Subjects:

The trend of risk scores. by Ayako Shoji (78037)

Subjects:

Fig 3 - by Ayako Shoji (78037)

Subjects:

Fig 1 - by Ayako Shoji (78037)

Subjects: